Farallon Capital portfolio and 13F holdings: the top 10 positions reported for 2026-06-30
The 10 largest positions Farallon Capital reported on Form 13F-HR for 2026-06-30, each at 0.5% or more of its portfolio and together 55.7% of everything it reported. Share, value and quarter-over-quarter change, straight from SEC EDGAR — no price data goes into the figures above.
Reported positions
Largest share first. Positions below 0.5% of the portfolio, and anything past the 10th, are not listed
| Ticker | Company | % of fund | Value | Change |
|---|---|---|---|---|
| Revolution Medicines Inc | 14.86% | $2.54 bn | new | |
| Electronic Arts Inc | 9.51% | $1.62 bn | increased | |
| BBIO | Bridgebio Pharma Inc | 4.68% | $800 m | new |
| Protagonist Therapeutics Inc | 4.56% | $778 m | new | |
| Exelixis Inc | 4.29% | $733 m | new | |
| Liquidia Corporation | 3.90% | $667 m | new | |
 AMZN | Amazon Com Inc | 3.67% | $628 m | new |
| Lantheus Hldgs Inc | 3.63% | $619 m | new | |
| Natera Inc | 3.52% | $602 m | new | |
| UnitedHealth Group, Inc. | 3.09% | $528 m | new |
Of the 10 positions above: new 9 · increased 1. The new ones are RVMD, BBIO, PTGX, EXEL, LQDA, AMZN, LNTH, NTRA, UNH. These labels come from comparing with the previous quarter's filing — Form 13F itself has no such column. Positions sold out during the quarter do not appear here at all.
Who else holds these names
Among the 59 funds we track, those reporting the same name as a top position. Not the total number of institutions holding it — funds we do not track, and smaller positions that miss the cut, do not appear. Each fund's as-of date is its own latest filing and is not necessarily the same quarter. Linked where we have a page for them
| Ticker | Funds | Also held by |
|---|---|---|
| 3 | Citadel Advisors, Soros Fund Management, Tudor Investment | |
| 1 | Renaissance Technologies | |
| AMZN | 29 | Altimeter Capital, Appaloosa, ARK Investment Management, Baillie Gifford, Baupost Group, Bridgewater Associates, Citadel Advisors, Coatue Management, D. E. Shaw, Dragoneer Investment, Duquesne Family Office, Fisher Asset Management, Glenview Capital, Gotham Asset Management, Marshall Wace, Maverick Capital, Millennium Management, Pershing Square, Point72, Polen Capital, Sands Capital, Soros Fund Management, Third Point, Tiger Global, Tudor Investment, Two Sigma Investments, ValueAct, Wedgewood Partners, Whale Rock Capital |
| 2 | Duquesne Family Office, Maverick Capital |
Farallon Capital portfolio value: what the 13F reports, and why it is not AUM
Farallon Capital reported $17.08 bn of positions on its Form 13F-HR for the quarter ending 2026-06-30, filed with the SEC on 2026-08-14 — 45 days after the quarter closed. By reported 13F value that makes it the 24th largest of the 59 funds tracked here, between Tiger Global ($23.98 bn) and Lone Pine Capital ($16.36 bn).
That $17.08 bn is the 13F portfolio value, not Farallon Capital's assets under management (AUM). A Form 13F lists the long positions a manager held in US-listed securities on the last day of the quarter. Cash, bonds, positions listed outside the United States, private investments and anything held short are not on the form, and options are left out of the figures on this page. Farallon Capital's total AUM can therefore be larger than $17.08 bn, and for a manager that also runs short positions the 13F shows only one side of the book. What the number does give you is exact: it is Farallon Capital's own count of its long US equity holdings on 2026-06-30, as filed.
Farallon Capital top holdings in Q2 2026: how concentrated the portfolio is
The largest position Farallon Capital reported is Revolution Medicines Inc (RVMD), at 14.86% of the portfolio — $2.54 bn. The top three — RVMD, EA and BBIO — add up to 29.0%, and the top five to 37.9%. All 10 positions listed here come to 55.7% of what the fund reported, or $9.52 bn. At 55.7% in 10 names the portfolio is moderately concentrated: the table covers the core of the book, with the remainder in smaller positions that are not listed here.
Compared with the filing for the quarter before: RVMD, BBIO, PTGX, EXEL, LQDA, AMZN, LNTH, NTRA and UNH are new positions; EA was added to. A position sold in full during the quarter drops off the form altogether, so exits cannot be read from this list.
Funds whose top holdings overlap most with Farallon Capital
Of the 10 positions above, Citadel Advisors reports 2 of the same names (EA, AMZN); Duquesne Family Office reports 2 of the same names (AMZN, NTRA); Maverick Capital reports 2 of the same names (AMZN, NTRA); Soros Fund Management reports 2 of the same names (EA, AMZN); Tudor Investment reports 2 of the same names (EA, AMZN). Overlap is counted against each fund's own largest reported positions, so a fund holding the same stock as a small position does not show up here.
Farallon Capital 13F: questions and answers
What is Farallon Capital's largest holding?
Revolution Medicines Inc (RVMD), at 14.86% of the reported portfolio ($2.54 bn) as of 2026-06-30. Electronic Arts Inc (EA) is second at 9.51%, followed by Bridgebio Pharma Inc (BBIO) at 4.68%.
What is Farallon Capital's AUM?
Its latest Form 13F reports $17.08 bn of long positions in US-listed securities for 2026-06-30. That is the 13F portfolio value rather than total AUM: cash, bonds, non-US listings, private holdings and short positions are not included, so the firm-wide figure Farallon Capital manages can differ from it.
What did Farallon Capital buy and sell in Q2 2026?
Among its 10 largest positions, the Q2 2026 filing shows new positions in RVMD, BBIO, PTGX, EXEL, LQDA, AMZN, LNTH, NTRA and UNH; additions to EA. The form compares share counts between two quarter ends, so it does not show the dates or prices of the trades, and positions sold out completely are absent rather than marked.
When does Farallon Capital file its next 13F?
The filing shown here covers the quarter ending 2026-06-30 and was filed on 2026-08-14, 45 days after quarter end. Form 13F is due within 45 days of each quarter end, so the next one — for the quarter ending 2026-09-30 — is due by 2026-11-14.
How many stocks does Farallon Capital hold?
This page lists its 10 largest reported positions, which cover 55.7% of the reported value. The full filing can contain more: positions below 0.5% of the portfolio, and anything past the top 10, are not listed here, so 10 is not the number of stocks Farallon Capital owns.
Source: SEC EDGAR, Form 13F-HR — public domain, reproduced as filed. The table above is not the fund's entire portfolio. The list is capped at 10, so the 10 shown add up to 55.7% of what the fund reported — the rest does not appear here. 13F carries up to a 45-day reporting delay, covers long positions in US-listed securities only, and excludes options and short positions. Values are as reported in the filing, not current market value. No price data is involved in the figures above. Names are EDGAR's own spelling.
See the 13F filings for Farallon Capital on SEC EDGAR
This page covers one fund in one quarter. Every fund, every quarter-over-quarter change and every insider purchase live in WhaleSignals.